SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2023 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (149)9/3/2023 8:51:44 PM
From: technetium3 Recommendations

Recommended By
Aloner
BulbaMan
Lance Bredvold

  Read Replies (1) of 233
 
As the leaves from the calendar fall, we have reached the first of September. August was a good month in the sense of not being a terrible one. Its last week was good for indices and more mixed for the portfolios. The NASDAQ composite up a healthy +3.2%, with the biotech indices registering gains as well, +1.5% for the NASDAQ biotech index and +3.1% for the S&P biotechs. The biotechs are definitely flirting with returning to a net profit for the year.

Looking at the portfolio choices it seems that most of our big movers are just bouncing around, week to week, KZIA: -9.4% last week, +19.1% this; ETON: up +22% then down -11%; BLCM: up +13% then down -27%, PSNL: down -12% then up +18%; OMER: up+12% then down -12%.. The only mover that correlated with press releases, was TWST (+16%) based on signing a “drug discovery agreement” with Ono Pharmaceuticals of Japan. TWST was also included in an analysts list of a “Artisan Small Cap Fund”. ETON’s loss of -11% for the week was in the teeth of a generally positive analyst report that dropped Tuesday.

It is also worth noting that the big losers for the week included two of the top five YTD performers, JSPR dropping -33% on top of a -29% loss last week (enough to drop it in the YTD rankings from second to third) and MOR, -13%.

For the portfolios generally, it was a week of treading water: a small improvement in the average portfolio of +$430. When we look at the specific portfolios roughly the same story, 7 portfolios in the black for the week, 7 in the red and one (the median) with an “accounting error” level of change (-$14). Our top winner for the week was STEVE LOKNESS (+$7.4k), thanks to a 15% holding in PSNL (+$2.7k) and 10% in PACB (+$1.8k), who were the fourth and third best performing stocks for the week. An additional +$1.6k and +$1.4k from NAUT and QSI helped also. This was enough to move him up from fourth to third place in the YTD standings (+$24k), switching with weighed down by JSPR, BLADERUNNER. A.J. MULLEN was in second place for the week (+$5.9k), holding both PACB and TWST, which was enough to rocket him up from last week’s median portfolio to 6th place, passing ARTHUR RADLEY now in seventh. ERIKOTTO and RKRW also switched places, now in second and third respectively. ALONER’s fourth place performance for the week helped open up his margin for first place YTD to $10k, ahead of ERIKOTTO.

A final bit of news, the acquisition of PRDS by MediaPacific was completed Thursday at an acquisition price of $2.13 / share. This resulted in a payout of $12,355.89 to the single portfolio that carried it, a Return on Investment of +24%. This cash was then reinvested into the portfolio’s remaining holdings, using Thursday’s closing prices as reported by Yahoo Finance.


Report Time Ranges











From

To

















Recent

8/25/2023

9/1/2023

















YTD

12/31/2022









Index Portfolios’ Performance









Symbol

Recent P/L

Recent %

YTD P/L

















^IXIC

$4,215.06

3.2%

$34,064.30

















^NBI

$1,473.94

1.5%

-$1,416.83

















^SPSIBI

$2,893.95

3.1%

-$2,323.21









Share Performance

Recent Performance

YTD Performance



Top Five



Bottom Five



Top Five



Bottom 5

Symbol

P/L / Initial Price

Symbol

P/L / Initial Price

Symbol

YTD P/L / Initial Price

Symbol

YTD P/L/ Initial Price

HUMA

22.3%

JSPR

-33.1%

INZY

360.0%

AVTX

-98.2%

KZIA

19.4%

BLCM

-27.1%

CRVS

150.6%

APTA.L

-97.7%

PACB

18.2%

MOR

-13.4%

JSPR

138.1%

PTEIQ

-87.2%

PSNL

17.7%

OMER

-11.9%

PRVB

136.5%

ALT

-83.9%

TWST

15.9%

ETON

-10.6%

MOR

107.3%

TCON

-82.4%

Average and Median Portfolio Performance



Recent P/L







YTD P/L







Avg.

Median







Avg

Median







$432.55

-$13.75

BMAZ001



-$5,376.84

-$10,410.87

TOMATO

Top Seven Portfolio Performances

Top Recent Performers

Top YTD Performers

Contestant (Prev. Rank)

Recent P/L

P/L vs. ^SPSIBI

YTD P/L (Rank)

Contestant (Prev. Rank)

YTD P/L

vs. Top Portfolio

P/L vs. ^SPSIBI

Rec. P/L (Rank)

1 - STEVE LOKNESS (8)

$7,440.92

$4,546.98

$20,993.11 (4)

1 - ALONER (1)

$35,177.46

——

$37,500.66

$2,642.87 (4)

2 - A.J. MULLEN (13)

$5,949.55

$3,055.60

-$5,648.72 (6)

2 - ERIKOTTO (3)

$24,932.31

$10,245.14

$27,255.52

-$2,265.94 (13)

3 - JACK HARTMANN (12)

$3,587.08

$693.13

-$13,923.24 (10)

3 - RKRW (2)

$24,414.16

$10,763.30

$26,737.37

-$3,432.95 (14)

4 - ALONER (14)

$2,642.87

-$251.08

$35,177.46 (1)

4 - STEVE LOKNESS (5)

$20,993.11

$14,184.35

$23,316.32

$7,440.92 (1)

5 - ARTHUR RADLEY (5)

$1,062.77

-$1,831.18

-$7,334.38 (7)

5 - BLADERUNNER (4)

$18,800.96

$16,376.50

$21,124.17

-$6,614.06 (15)

6 - DEW DILIGENCE (2)

$920.23

-$1,973.71

-$20,037.29 (12)

6 - A.J. MULLEN (8)

-$5,648.72

$40,826.18

-$3,325.52

$5,949.55 (2)

7 - TECHNETIUM (4)

$483.86

-$2,410.09

-$13,641.53 (9)

7 - ARTHUR RADLEY (6)

-$7,334.38

$42,511.83

-$5,011.17

$1,062.77 (5)

Top Portfolios’ Contents

Top Recent Performance Portfolio (STEVE LOKNESS)

Top YTD Performance Portfolio (ALONER)

Symbol (Rank)

Current Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

AKYA

15.0%

6.9% | -44.5%

-$6,677.12

$156.74

12.0%

AFMD

10%

4.4% | -53.2%

-$6,718.32

-$99.96

16.9%

CRBU

5.0%

3.9% | -6.4%

-$318.47

-$302.55

21.4%

CDTX

10%

9.2% | -1.5%

-$186.14

$236.24

8.0%

GRPH

10.0%

5.6% | -32.2%

-$3,222.89

-$632.53

14.8%

CLSD

10%

7.7% | -17.1%

-$2,159.56

-$346.30

9.6%

MGTA

10.0%

15.6% | 88.4%

$8,837.97

-$48.10

5.3%

CRDF

10%

12.2% | 30.1%

$3,806.02

$88.83

6.1%

MRUS

15.0%

18.6% | 50.1%

$7,514.54

$872.66

4.4%

CRIS

10%

9.2% | -1.4%

-$176.78

-$238.74

8.0%

NAUT

10.0%

15.7% | 89.4%

$8,944.44

$1,555.56

5.3%

CRVS

10%

22.2% | 137.3%

$17,341.02

$844.20

3.3%

PACB

10.0%

11.5% | 39.5%

$3,948.66

$1,821.52

7.2%

KZIA

10%

13.1% | 39.8%

$5,021.31

$2,165.22

5.7%

PSNL

15.0%

11.6% | -6.6%

-$984.85

$2,651.52

7.1%

MGTA

10%

15.8% | 68.8%

$8,685.29

-$54.42

4.7%

QSI

10.0%

10.7% | 29.5%

$2,950.82

$1,366.12

7.7%

MRNA

10%

6.3% | -32.4%

-$4,087.22

$47.80

11.7%













PRVB

10%

0.0% | 136.5%

$13,651.84

$0.00

--
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext